24.75
price up icon0.61%   0.15
pre-market  Vorhandelsmarkt:  24.75  
loading

Lenz Therapeutics Inc Aktie (LENZ) Neueste Nachrichten

pulisher
Mar 11, 2025

LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025 - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

LENZ Therapeutics Q4 Earnings: Key Updates Coming on Presbyopia Eye Drops - StockTitan

Mar 11, 2025
pulisher
Mar 09, 2025

Rhumbline Advisers Boosts Stock Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Mar 09, 2025
pulisher
Mar 03, 2025

LENZ Therapeutics to Host Commercial Day on April 15, 2025 - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

Will LENZ's Presbyopia Eye Drop Disrupt the Vision Care Market? Commercial Strategy Reveal Coming - StockTitan

Mar 03, 2025
pulisher
Feb 25, 2025

Insiders Enjoy US$227k Return After Buying LENZ Therapeutics Stock - Simply Wall St

Feb 25, 2025
pulisher
Feb 24, 2025

LENZ Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

LENZ Therapeutics to Present at Upcoming Investor Conferences in March 2025 - Nasdaq

Feb 24, 2025
pulisher
Feb 24, 2025

Can LENZ's Novel Presbyopia Treatment Disrupt the $8B Eye Care Market? Key Investor Presentations Coming - StockTitan

Feb 24, 2025
pulisher
Feb 23, 2025

Myopia And Presbyopia Eye Drops Market Future Business - openPR

Feb 23, 2025
pulisher
Feb 21, 2025

LENZ Therapeutics (LENZ) to Release Quarterly Earnings on Wednesday - Defense World

Feb 21, 2025
pulisher
Feb 19, 2025

LENZ Therapeutics Insiders Placed Bullish Bets Worth US$551.1k - Yahoo Finance UK

Feb 19, 2025
pulisher
Feb 18, 2025

Citi maintains Buy on LENZ Therapeutics, target at $44 By Investing.com - Investing.com Canada

Feb 18, 2025
pulisher
Feb 18, 2025

Citi maintains Buy on LENZ Therapeutics, target at $44 - Investing.com

Feb 18, 2025
pulisher
Feb 16, 2025

Mirae Asset Global Investments Co. Ltd. Makes New Investment in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Feb 16, 2025
pulisher
Feb 16, 2025

916 Shares in LENZ Therapeutics, Inc. (NASDAQ:LENZ) Acquired by Mirae Asset Global Investments Co. Ltd. - Defense World

Feb 16, 2025
pulisher
Feb 13, 2025

LENZ Therapeutics (NASDAQ:LENZ) Shares Down 4.7%Should You Sell? - MarketBeat

Feb 13, 2025
pulisher
Feb 10, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Acquired by SG Americas Securities LLC - Defense World

Feb 10, 2025
pulisher
Feb 07, 2025

The Presbyopia Market Size to Reach USD 2,513.0 Million by 2035, Impelled by Technological Advancements in Diagnostic Tools - BioSpace

Feb 07, 2025
pulisher
Feb 07, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Feb 07, 2025
pulisher
Feb 06, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives $35.40 Average Target Price from Brokerages - Defense World

Feb 06, 2025
pulisher
Feb 04, 2025

LENZ Therapeutics (NASDAQ:LENZ) Trading 8% HigherWhat's Next? - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

Research Analysts Set Expectations for LENZ FY2025 Earnings - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

LENZ Therapeutics (NASDAQ:LENZ) Trading Down 5.1%What's Next? - MarketBeat

Feb 02, 2025
pulisher
Feb 01, 2025

LENZ Therapeutics (LENZ) to Release Earnings on Wednesday - MarketBeat

Feb 01, 2025
pulisher
Feb 01, 2025

Leerink Partnrs Has Pessimistic View of LENZ FY2025 Earnings - Defense World

Feb 01, 2025
pulisher
Jan 31, 2025

More Heart, Less Skin: US FDA’s 2025 Novel Approvals Should Reflect Pipeline Shifts - News & Insights

Jan 31, 2025
pulisher
Jan 30, 2025

Yankuang Energy Group Company Limited (OTCMKTS:YZCAY) Sees Large Decrease in Short Interest - Defense World

Jan 30, 2025
pulisher
Jan 29, 2025

Myopia Pipeline 2024: Detailed Clinical Trials - openPR

Jan 29, 2025
pulisher
Jan 29, 2025

LENZ Therapeutics (LENZ) Expected to Announce Earnings on Wednesday - Defense World

Jan 29, 2025
pulisher
Jan 25, 2025

Barclays PLC Sells 1,835 Shares of Grupo Financiero Galicia S.A. (NASDAQ:GGAL) - Defense World

Jan 25, 2025
pulisher
Jan 23, 2025

Presbyopia Market on Track for Major Expansion by 2034, According to DelveInsight - EIN News

Jan 23, 2025
pulisher
Jan 20, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Sees Significant Increase in Short Interest - Defense World

Jan 20, 2025
pulisher
Jan 20, 2025

Lincoln Electric Holdings, Inc. (NASDAQ:LECO) Short Interest Down 5.0% in December - Defense World

Jan 20, 2025
pulisher
Jan 20, 2025

LifeVantage Co. (NASDAQ:LFVN) Short Interest Down 5.4% in December - Defense World

Jan 20, 2025
pulisher
Jan 20, 2025

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Sees Significant Increase in Short Interest - Defense World

Jan 20, 2025
pulisher
Jan 20, 2025

Morgan Stanley Cuts U.S. Bancorp (NYSE:USB) Price Target to $59.00 - Defense World

Jan 20, 2025
pulisher
Jan 19, 2025

Short Interest in LENZ Therapeutics, Inc. (NASDAQ:LENZ) Expands By 11.9% - MarketBeat

Jan 19, 2025
pulisher
Jan 19, 2025

Barclays PLC Has $391,000 Stake in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Jan 19, 2025
pulisher
Jan 19, 2025

Barclays PLC Buys 12,051 Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat

Jan 19, 2025
pulisher
Jan 17, 2025

LENZ Therapeutics (NASDAQ:LENZ) Trading Down 5%Time to Sell? - MarketBeat

Jan 17, 2025
pulisher
Jan 14, 2025

Trio-Tech International (NYSE:TRT) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

Harbor Capital Advisors Inc. Buys Shares of 43,989 LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat

Jan 13, 2025
pulisher
Jan 12, 2025

Brokerages Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) PT at $35.40 - Defense World

Jan 12, 2025
pulisher
Jan 11, 2025

Jane Street Group LLC Acquires Shares of 12,027 LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Jan 11, 2025
pulisher
Jan 10, 2025

LENZ Therapeutics (NASDAQ:LENZ) Shares Down 8.9%Here's What Happened - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Intellia stock hurts gene editing after layoffs (NTLA:NASDAQ) - Seeking Alpha

Jan 10, 2025
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Kapitalisierung:     |  Volumen (24h):